Sanofi Genzyme is the specialty care global business unit of Sanofi. We strive to help people with complex conditions that may be difficult to treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com. MAT-US-2021560-v1.0-11/20
Featured Content
Trial in mCRPC: Chemotherapy vs Abiraterone or Enzalutamide »
